Safety study of a new drug HMB-003 in healthy adults
This study is testing a new investigational drug called HMB-003 to see how safe it is and how it behaves in the body. It is for healthy volunteers and will help determine whether the drug can be studied further in people with certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 50 years old.
- You must be in good overall health, as judged by a doctor.
- You must not have a history of severe allergic reactions to any component of the study drug.
- If you are female, you must not be pregnant or breastfeeding, and must be at least 6 weeks after giving birth.
- You must not have participated in another clinical trial involving an investigational drug or device within the past 30 days or 5 half-lives of that drug, whichever is longer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This trial tests a new medicine called HB0034 in healthy volunteers. It helps researchers understand how the drug works in the body before testing it in people with a medical condition.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.